Viewing Study NCT01081756


Ignite Creation Date: 2025-12-24 @ 11:38 PM
Ignite Modification Date: 2026-02-24 @ 11:01 AM
Study NCT ID: NCT01081756
Status: COMPLETED
Last Update Posted: 2014-07-31
First Post: 2010-03-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study Using Recombinant Human Chorionic Gonadotrophin (rhCG, OvidrelĀ®) in the Induction of Final Follicle Maturation and Early Luteinization in Chinese Women Undergoing in Vitro Fertilization and Embryo Transfer (IVF/ET)
Sponsor: Merck KGaA, Darmstadt, Germany
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module